September 2024

SOUTH SAN FRANCISCO, Calif., Sept. 30, 2024 /PRNewswire/ — Spiral Therapeutics, Inc. (Spiral), a clinical-stage company focused on developing novel therapies for inner ear disorders, announced the successful completion of the Phase 1b/2a clinical trial of SPT-2101 (6% dexamethasone) in Meniere

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: